tPA by Endovascular Administration for the Treatment of Submassive PE Using CDT for the Reduction of Thrombus Burden
Status:
Recruiting
Trial end date:
2022-09-01
Target enrollment:
Participant gender:
Summary
To demonstrate the efficacy and safety of the Bashir™ Endovascular Catheter for the
administration of pharmaco-mechanical catheter directed therapy using low dose r-tPA for the
treatment of acute submassive pulmonary embolism.